Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & ...

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...

Blood and saliva tests to detect cancer before symptoms begin ‘could be part of NHS screening within a decade’ - The ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech continues to gather up trial data for a potential FDA approval next year.  | Telehealth ...

Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte ...

On World Cancer Day, we look at the companies accelerating breakthroughs across the cancer pipeline, from screening to recovery.

The emergency department at Rosthern Hospital has been equipped with point-of-care testing technology, a move aimed at ...

Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...

Investing.com -- Hims & Hers Health, Inc. (NYSE:HIMS) stock rose 6% on Wednesday after the digital health platform announced it is launching access to a multi-cancer early detection test that can ...

The Government has set out how it intends to transform cancer detection and treatment in a new 10-year plan.

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...

NHS patients will be told their real-time cancer risk with the help of gadgets such as smartwatches. Everyone will be able to access “real-time personalised insights about their cancer risk” within a ...